Belfast-based AMPLY Discovery raises €1.6 million to tackle complex diseases with drug discovery platform
Published on February 12, 2024
Belfast-based techbio company AMPLY Discovery announced that it has raised over €1.6 million in grant funding from Innovate UK to develop new drug products using its proprietary AI-driven drug discovery platform. AMPLY’s existing investors include Co-fund NI, which is managed by Clarendon Fund Managers and supported by Invest NI and the British Business Bank, QUBIS…
The post Belfast-based AMPLY Discovery raises €1.6 million to tackle complex diseases with drug discovery platform appeared first on EU-Startups.
